Shuttle Pharmaceuticals Inc (SHPH) Financials
$3.50
As on 09-Sep-2026 16:02EDT
Market cap
$2 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
35
P/B Ratio
0.6
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cost of Revenue
|
0.92
|
0.29
|
0.01
|
0.01
|
0.01
|
0.06
|
|||||
|
Gross Profit
|
-0.92
|
-0.29
|
-0.01
|
-0.01
|
-0.01
|
-0.06
|
|||||
|
Operating Expenses
|
10.26
|
11.92
|
7.70
|
5.89
|
2.34
|
1.68
|
|||||
|
Operating Profit (EBIT)
|
-11.18
|
-11.92
|
-7.70
|
-5.89
|
-2.34
|
-1.74
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-10.82
|
-11.72
|
-9.14
|
-6.59
|
-5.00
|
-1.15
|
|||||
|
Provision for Tax
|
--
|
--
|
--
|
0.00
|
0.07
|
0.05
|
|||||
|
Profit after Tax (Net Income)
|
-10.82
|
-11.72
|
-9.14
|
-6.59
|
-5.00
|
-1.15
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
-3.10
|
-1.26
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
3.35
|
2.25
|
0.71
|
4.06
|
7.68
|
-1.63
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
0.16
|
0.25
|
0.26
|
0.85
|
--
|
0.06
|
|||||
|
Current Liabilities
|
8.31
|
7.97
|
1.53
|
1.04
|
0.98
|
2.22
|
|||||
|
Total Liabilities
|
20.11
|
10.48
|
2.51
|
5.95
|
8.65
|
0.65
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
9.35
|
9.97
|
0.30
|
0.36
|
0.08
|
0.14
|
|||||
|
Current Assets
|
2.46
|
0.50
|
2.21
|
5.59
|
8.58
|
0.51
|
|||||
|
Total Assets
|
20.11
|
10.48
|
2.51
|
5.95
|
8.65
|
0.65
|
|||||
|
Total Debt*
|
0.21
|
0.23
|
1.17
|
1.09
|
0.75
|
0.98
|
|||||
|
Net Current Assets
|
-5.84
|
-7.46
|
0.68
|
4.55
|
7.60
|
-1.71
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-9.48
|
-7.33
|
-5.58
|
-2.71
|
-0.30
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-3.06
|
2.92
|
-2.83
|
--
|
--
|
|||||
|
Cash from Financing Activities
|
--
|
10.95
|
3.76
|
2.57
|
10.62
|
0.69
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-60.62
|
-57.91
|
-22.43
|
-4.10
|
-3.67
|
-0.85
|
|||||
|
Cash EPS ($)
|
--
|
-56.48
|
-22.42
|
-4.06
|
-3.62
|
-0.84
|
|||||
|
Adjusted Book Value ($)
|
--
|
11.14
|
1.74
|
2.52
|
5.64
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
-46.85
|
-17.97
|
-3.47
|
-1.99
|
-0.22
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
-46.85
|
-17.97
|
-3.49
|
-1.99
|
-0.22
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-536.56
|
-260.31
|
-97.17
|
-128.48
|
157.26
|
|||||
|
ROE (%)
|
-456.55
|
-791.04
|
-383.84
|
-112.37
|
-165.17
|
69.44
|
|||||
|
ROA (%)
|
-79.55
|
-180.58
|
-216.24
|
-90.28
|
-107.38
|
-192.71
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Net Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
-12.07
|
-49.66
|
-94.74
|
7.58
|
-292.74
|
-43.76
|
|||||
|
Net Profit Growth (%)
|
-3.39
|
-28.18
|
-38.71
|
-31.96
|
-333.64
|
-42.99
|
|||||
|
EPS Growth (%)
|
-255.73
|
-1.58
|
-4.47
|
-0.12
|
-3.33
|
--
|
|||||
|
Book Value Growth (%)
|
-17.47
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
35.00
|
-0.03
|
-0.04
|
-0.11
|
-0.53
|
--
|
|||||
|
Price / Book Value
|
0.61
|
0.16
|
0.49
|
0.18
|
0.35
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-0.67
|
-0.02
|
0.42
|
0.91
|
1.16
|
--
|
|||||
|
Close Price ($)
|
6.79
|
18.00
|
214.75
|
910.00
|
3,920.00
|
--
|
|||||
|
High Price ($)
|
136.30
|
252.50
|
1,236.00
|
5,740.00
|
252,520.00
|
--
|
|||||
|
Low Price ($)
|
5.00
|
12.60
|
145.00
|
840.00
|
2,700.00
|
--
|
|||||
|
Market Cap ($ Cr)
|
2.05
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.10
|
1.65
|
0.27
|
0.10
|
-0.60
|
|||||
|
Short term debt to equity ratio
|
0.02
|
0.03
|
1.32
|
0.16
|
0.10
|
-0.56
|
|||||
|
Current Ratio
|
0.30
|
0.06
|
1.44
|
5.37
|
8.79
|
0.23
|
|||||
|
Quick Ratio
|
0.30
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Interest Coverage
|
-151.37
|
-164.49
|
-5.72
|
-1.54
|
-6.45
|
-21.69
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Asset Turnover
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Receivable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Payable days
|
--
|
1,290.73
|
29,414.76
|
11,061.83
|
29,282.32
|
4,038.56
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|